Inactive Instrument
Guided Therapeutics Inc Share Price OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 26.55M 23.29M 21.57M 19.85M 37.45M 2.55B 37.93M 257M 101M 1.25B 99.66M 97.51M 4.33B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 29.42M 25.81M 23.91M 22M 41.51M 2.83B 42.04M 285M 112M 1.39B 110M 108M 4.8B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 05/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 01/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 30/11/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 09/04/2006 |
Michael James
CHM | Chairman | 67 | 30/09/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.53% | -0.96% | +26.21% | -2.75% | 196B | ||
| -10.99% | -10.57% | -5.81% | -26.75% | 142B | ||
| -0.88% | -14.02% | -32.50% | +0.69% | 125B | ||
| -1.33% | -3.27% | -58.33% | -19.21% | 65.06B | ||
| -0.53% | -7.89% | +10.54% | -8.74% | 48.94B | ||
| -2.38% | -2.95% | -25.16% | -32.78% | 44.9B | ||
| +2.00% | -0.88% | +16.55% | +6.67% | 36.79B | ||
| +2.80% | -1.52% | +27.83% | +31.38% | 35.11B | ||
| -1.41% | -1.36% | -24.08% | -10.71% | 28.65B | ||
| Average | -1.26% | -3.21% | -7.19% | -6.91% | 80.27B | |
| Weighted average by Cap. | -2.25% | -2.97% | -4.54% | -8.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.14K 5.69K 5.23K 9.87K 674K 10K 67.88K 26.55K 330K 26.28K 25.71K 1.14M | 767K 673K 623K 573K 1.08M 73.8M 1.1M 7.44M 2.91M 36.18M 2.88M 2.82M 125M |
| Net income | -2.42M -2.12M -1.96M -1.81M -3.41M -233M -3.45M -23.44M -9.17M -114M -9.07M -8.88M -394M | -3.2M -2.8M -2.6M -2.39M -4.51M -308M -4.57M -30.99M -12.12M -151M -12M -11.74M -521M |
| Net Debt | 1.77M 1.55M 1.44M 1.32M 2.5M 170M 2.53M 17.17M 6.72M 83.55M 6.65M 6.5M 289M | 2.88M 2.52M 2.34M 2.15M 4.06M 277M 4.11M 27.89M 10.91M 136M 10.8M 10.56M 469M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















